Company Filing History:
Years Active: 2012-2018
Title: Jürgen Stiehl: Innovator in Pharmaceutical Chemistry
Introduction
Jürgen Stiehl is a notable inventor based in Sprockhövel, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative methods and processes. With a total of two patents to his name, Stiehl has demonstrated his expertise and commitment to advancing medical science.
Latest Patents
Stiehl's latest patents include a novel method for the synthesis of copanlisib and its dihydrochloride salt. This invention relates to the preparation of copanlisib and its intermediate compounds, which are crucial for its development. Additionally, he has patented a process for preparing 4-{4-[({[4-chloro-3-(trifluoromethyl)phenyl]amino}carbonyl)amino]phenoxy}-N-methylpyridine-2-carboxamide and its tosylate salt. These patents highlight his innovative approach to complex chemical processes.
Career Highlights
Throughout his career, Jürgen Stiehl has worked with prominent companies in the pharmaceutical industry, including Bayer Pharma Aktiengesellschaft and Bayer Healthcare LLC. His experience in these organizations has allowed him to refine his skills and contribute to significant advancements in drug development.
Collaborations
Stiehl has collaborated with esteemed colleagues such as Michael Lögers and Reinhold Gehring. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Jürgen Stiehl's contributions to pharmaceutical chemistry through his patents and collaborations underscore his role as a key innovator in the field. His work continues to impact the development of important medical compounds.